Though the smallest of Medtronic’s four core businesses, the diabetes department has taken center stage as of late. Fresh off reaching a resolution with the FDA over a warning letter concerning its ...

Last week was a busy one for makers of diabetes devices, with the FDA expanding the approval of Dublin-based Medtronic plc's Minimed 670G hybrid closed looped system, and San Diego's Tandem Diabetes ...

About half a year after announcing its intent to acquire a South Korean maker of tubeless insulin pump technology, Medtronic is scrapping the deal. In an 8-K filing (PDF) with the U.S. Securities and ...

FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) -The U.S. Food and Drug Administration on Tuesday warned that certain types of insulin pump systems ...

Acquisition will expand company's ability to serve more people living with diabetes around the world within one seamless Medtronic ecosystem of support "Our goal is to simplify diabetes management and ...

Using an insulin pump is an act of profound trust. Diabetic patients wear their insulin pumps at virtually all hours, relying on the medical machinery to administer doses of a potentially lethal ...

Customers are being notified of the importance of checking built-in alerts and alarms for battery status and to contact Medtronic for pump replacement if affected by this issue GALWAY, Ireland, Oct. 4 ...

Medtronic is recalling remote controllers used with its MiniMed 508 insulin pump and MiniMed Paradigm family of insulin pumps due to dangerous security flaws. The Food and Drug Administration on ...

Medtronic devices comprise an estimated 60% of the insulin pump market. Image: Medtronic Medical device maker Medtronic has expanded its recall of remote controllers for its MiniMed 508 and MiniMed ...

Medtronic is urgently recalling remote controllers for insulin pumps belonging to the ‘MiniMed Paradigm’ family of products, due to severe cybersecurity risks. The controllers that should be returned ...

Abbott Laboratories is linking its continuous glucose monitoring with automated insulin delivery by entering a global partnership with health tech giant Medtronic. The pairing of Abbott's leading ...